Optimizing electronic blood ordering and supporting administration workflows to improve blood utilization in the pediatric hospital setting.


Journal

Transfusion
ISSN: 1537-2995
Titre abrégé: Transfusion
Pays: United States
ID NLM: 0417360

Informations de publication

Date de publication:
Dec 2023
Historique:
revised: 04 09 2023
received: 08 05 2023
accepted: 08 09 2023
medline: 7 12 2023
pubmed: 9 11 2023
entrez: 9 11 2023
Statut: ppublish

Résumé

Red blood cell wastage occurs when blood is discarded rather than transfused, and ineffective ordering results in unnecessary crossmatch procedures. We describe how a multimodal approach to redesigning electronic ordering tools improved blood utilization in a pediatric inpatient setting and how using innovative application of time series data analysis provides insights into intervention effectiveness, which can guide future process improvement cycles. A multidisciplinary team used best practices and Toyota Production System methodology to redesign electronic blood ordering and improve administration processes. We analyzed crossmatch to transfusion ratio and red blood cell wastage time series data extracted from our laboratory information system and electronic health record. We used changepoint analysis to identify statistically discernible breaks in each time series, compatible with known interventions. We performed causal impact analysis on red blood cell wastage time series data to estimate blood wastage avoided due to the interventions. Changepoint analysis estimated an 11% decrease in crossmatch to transfusion ratio and a 77% decrease in red blood cell monthly wastage rate during the intervention period. Causal impact analysis estimated a 61% reduction in expected wastage compared to the scenario if the interventions had not occurred. Our results show that electronic health record design is an important factor in reducing waste and preventing unnecessary crossmatching, and that time series analysis can be a useful tool for evaluating the long-term impact of each stage of intervention in a longitudinal process redesign effort for the purpose of effectively targeting future improvement efforts.

Sections du résumé

BACKGROUND BACKGROUND
Red blood cell wastage occurs when blood is discarded rather than transfused, and ineffective ordering results in unnecessary crossmatch procedures. We describe how a multimodal approach to redesigning electronic ordering tools improved blood utilization in a pediatric inpatient setting and how using innovative application of time series data analysis provides insights into intervention effectiveness, which can guide future process improvement cycles.
METHODS METHODS
A multidisciplinary team used best practices and Toyota Production System methodology to redesign electronic blood ordering and improve administration processes. We analyzed crossmatch to transfusion ratio and red blood cell wastage time series data extracted from our laboratory information system and electronic health record. We used changepoint analysis to identify statistically discernible breaks in each time series, compatible with known interventions. We performed causal impact analysis on red blood cell wastage time series data to estimate blood wastage avoided due to the interventions.
RESULTS RESULTS
Changepoint analysis estimated an 11% decrease in crossmatch to transfusion ratio and a 77% decrease in red blood cell monthly wastage rate during the intervention period. Causal impact analysis estimated a 61% reduction in expected wastage compared to the scenario if the interventions had not occurred.
DISCUSSION CONCLUSIONS
Our results show that electronic health record design is an important factor in reducing waste and preventing unnecessary crossmatching, and that time series analysis can be a useful tool for evaluating the long-term impact of each stage of intervention in a longitudinal process redesign effort for the purpose of effectively targeting future improvement efforts.

Identifiants

pubmed: 37942518
doi: 10.1111/trf.17587
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2328-2340

Informations de copyright

© 2023 The Authors. Transfusion published by Wiley Periodicals LLC on behalf of AABB.

Références

Al-Riyami AZ, Burnouf T, Wood EM, Devine DV, Oreh A, Apelseth TO, et al. International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic. Vox Sang. 2022;117(6):822-830.
Chandler T, Neumann-Böhme S, Sabat I, Barros PP, Brouwer W, van Exel J, et al. Blood donation in times of crisis: early insight into the impact of COVID-19 on blood donors and their motivation to donate across European countries. Vox Sang. 2021;116(10):1031-1041.
Seattle Children's Fiscal Year 2021 Facts and Stats [Internet]. Seattle Children's hospital website. [cited 2022 Nov 11]. Available from https://www.seattlechildrens.org/about/facts-and-stats
Zeileis A, Leisch F, Hornik K, Kleiber C. Strucchange: an R package for testing for structural change in linear regression models. J Stat Softw. 2002;7:1-38.
Zeileis A, Kleiber C, Krämer W, Hornik K. Testing and dating of structural changes in practice. Comput Stat Data Anal. 2003;44(1):109-123.
R Core Team. European Environment Agency website. [cited 2021 Oct 25]. Available from 2020 https://www.eea.europa.eu/data-and-maps/indicators/oxygen-consuming-substances-in-rivers/r-development-core-team-2006
Burnham KP, Anderson DR, editors. Information and likelihood theory: a basis for model selection and inference. Model selection and multimodel inference: a practical information-theoretic approach. New York, NY: Springer; 2002 [cited 2021 Oct 25]. p. 49-97. Available from. https://doi.org/10.1007/978-0-387-22456-5_2
Brodersen KH, Gallusser F, Koehler J, Remy N, Scott SL. Inferring causal impact using Bayesian structural time-series models. Ann Appl Stat. 2015 [cited 2021 Oct 25];9(1):247-274. Available from http://arxiv.org/abs/1506.00356
Adams ES, Longhurst CA, Pageler N, Widen E, Franzon D, Cornfield DN. Computerized physician order entry with decision support decreases blood transfusions in children. Pediatrics. 2011;127(5):e1112-e1119.
Mowla SJ, Sapiano MRP, Jones JM, Berger JJ, Basavaraju SV. Supplemental findings of the 2019 National Blood Collection and utilization survey. Transfusion. 2021;61(S2):S11-S35.
Campbell RJ. The five rights of clinical decision support: CDS tools helpful for meeting meaningful use. J AHIMA. 2013;84(10):42-47.
Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digit Med. 2020;3(1):17.
Liker JK. The Toyota way: 14 management principles from the World's greatest manufacturer. 1st ed. New York: McGraw-Hill Education; 2004. p. 330.
Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46(1):348-355.
Ansari F, Gray K, Nathwani D, Phillips G, Ogston S, Ramsay C, et al. Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J Antimicrob Chemother. 2003;52(5):842-848.
Fretheim A, Tomic O. Statistical process control and interrupted time series: a golden opportunity for impact evaluation in quality improvement. BMJ Qual Saf. 2015;24(12):748-752.
Kassakian SZ, Yackel TR, Deloughery T, Dorr DA. Clinical decision support reduces overuse of red blood cell transfusions: interrupted time series analysis. Am J Med. 2016;129(6): 636.e13-20.
Vanneman MW, Balakrishna A, Lang AL, Eliason KD, Payette AM, Xu X, et al. Improving transfusion safety in the operating room with a barcode scanning system designed specifically for the surgical environment and existing electronic medical record systems: an interrupted time series analysis. Anesth Analg. 2020;131(4):1217-1227.
Kracalik I, Mowla S, Katz L, Cumming M, Sapiano MRP, Basavaraju SV. Impact of the early coronavirus disease 2019 pandemic on blood utilization in the United States: a time-series analysis of data reported to the National Healthcare Safety Network Hemovigilance Module. Transfusion. 2021;61(S2):S36-S43.
Wu D, Faria AV, Younes L, Ross CA, Mori S, Miller MI. Whole-brain segmentation and change-point analysis of anatomical brain MRI-application in premanifest Huntington's disease. J Vis Exp. 2018;136:57256.
Holland WC, Nath B, Li F, Maciejewski K, Paek H, Dziura J, et al. Interrupted time series of user-centered clinical decision support implementation for emergency department-initiated buprenorphine for opioid use disorder. Acad Emerg Med. 2020;27(8):753-763.
Chhapola V, Sharma AG, Kanwal SK, Kumar V, Patra B. Neonatal exchange transfusions at a tertiary care Centre in North India: an investigation of historical trends using change-point analysis and statistical process control. Int Health. 2018;10(6):451-456.
Navas Thorakkattle M, Farhin S, Khan AA. Forecasting the trends of Covid-19 and causal impact of vaccines using Bayesian structural time series and ARIMA. Ann Data Sci. 2022;9(5):1025-1047.
Pinilla J, Negrín M, González-López-Valcárcel B, Vázquez-Polo FJ. Using a Bayesian structural time-series model to infer the causal impact on cigarette sales of partial and Total bans on public smoking. Jahrbücher für Nationalökonomie Und Statistik. 2018;238(5):423-439.
Liu J, Spakowicz DJ, Hoyd R, Ash GI, Lou S, Lee D, et al. Bayesian structural time series for mobile health and sensor data: a flexible modeling framework for evaluating interventions bioRxiv. 2020 2020.03.02.973677.
Blood Transfusions for Anemia in the Hospital [Internet]. Choosing Wisely website. 2015 [cited 2022 Dec 26]. Available from https://www.choosingwisely.org/patient-resources/blood-transfusions-for-anemia-in-the-hospital/
Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion. 2010;50(4):753-765.
Stokes EA, Wordsworth S, Staves J, Mundy N, Skelly J, Radford K, et al. Accurate costs of blood transfusion: a microcosting of administering blood products in the United Kingdom National Health Service. Transfusion. 2018;58(4):846-853.
Ferguson E, Dawe-Lane E, Khan Z, Reynolds C, Davison K, Edge D, et al. Trust and distrust: identifying recruitment targets for ethnic minority blood donors. Transfus Med. 2022;32(4):276-287.
Weidmann C, Derstroff M, Klüter H, Oesterer M, Müller-Steinhardt M. Motivation, blood donor satisfaction and intention to return during the COVID-19 pandemic. Vox Sang. 2022;117(4):488-494.

Auteurs

Michelle Stoffel (M)

Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, Washington, USA.
Department of Laboratory Medicine & Pathology, University of Minnesota, Minneapolis, Minnesota, USA.

Michael G Leu (MG)

Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, Washington, USA.
Clinical Effectiveness, Seattle Children's Hospital, Seattle, Washington, USA.
Department of Pediatrics, University of Washington, Seattle, Washington, USA.
Department of Information Technology Services, University of Washington School of Medicine, Seattle, Washington, USA.

Dwight Barry (D)

Clinical Analytics, Seattle Children's Hospital, Seattle, Washington, USA.

Jennifer Hrachovec (J)

Clinical Effectiveness, Seattle Children's Hospital, Seattle, Washington, USA.
Center for Quality and Patient Safety, Seattle Children's Hospital, Seattle, Washington, USA.

Nabiha H Saifee (NH)

Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
Department of Laboratories, Seattle Children's Hospital, Seattle, Washington, USA.

Darren S Migita (DS)

Clinical Effectiveness, Seattle Children's Hospital, Seattle, Washington, USA.
Center for Quality and Patient Safety, Seattle Children's Hospital, Seattle, Washington, USA.

Nate Deam (N)

Clinical Analytics, Seattle Children's Hospital, Seattle, Washington, USA.
Analytics, Children's Minnesota, Minneapolis, Minnesota, USA.

Carlos E Villavicencio (CE)

Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, Washington, USA.
Department of Pediatrics, University of Washington, Seattle, Washington, USA.
Department of Information Technology Services, University of Washington School of Medicine, Seattle, Washington, USA.

M Pauline O'Hare (MP)

Clinical Effectiveness, Seattle Children's Hospital, Seattle, Washington, USA.
Center for Quality and Patient Safety, Seattle Children's Hospital, Seattle, Washington, USA.

Amy Pagliarulo (A)

Department of Laboratories, Seattle Children's Hospital, Seattle, Washington, USA.
Iovance Biotherapeutics, San Carlos, California, USA.

Meghan Delaney (M)

Division of Pathology and Laboratory Medicine, Children's National Hospital, Washington, DC, USA.
Department of Pathology and Pediatrics, George Washington University Medical School, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH